ARTICLE | Company News
Aeterna Zentaris, Tulane University deal
November 1, 2004 8:00 AM UTC
AEZ received exclusive worldwide rights to develop and commercialize growth hormone-releasing hormone ( GHRH) antagonists for all indications including cancer and endocrine disorders. Tulane will rec...